SEC CIK 1524338
LARANJEIRA CHARLES ANTHONY
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| PCRXview stock → | 41,752 | 2022-06-14 |
Position History — PCRX
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — PCRX
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2022-06-14 | Option exercise (derivative) | 6,000 | $0.00 | 9,000 |
| 2022-06-14 | Option exercise | 6,000 | $38.35 | 41,752 |
| 2022-06-08 | Grant / award (derivative) | 24,800 | $0.00 | 24,800 |
| 2022-06-08 | Open-market sale | 267 | $61.98 | 25,852 |
| 2022-06-08 | Open-market sale | 516 | $60.99 | 26,119 |
| 2022-06-08 | Grant / award | 9,900 | $0.00 | 35,752 |
| 2022-06-08 | Open-market sale | 2,521 | $59.08 | 28,268 |
| 2022-06-08 | Open-market sale | 1,633 | $60.23 | 26,635 |
| 2022-06-06 | Open-market sale | 2,813 | $61.37 | 30,789 |
| 2021-11-22 | Option exercise (derivative) | 7,500 | $0.00 | 0 |
| 2021-11-22 | Option exercise | 7,500 | $44.10 | 33,602 |
| 2021-06-09 | Grant / award (derivative) | 17,500 | $0.00 | 17,500 |
| 2021-06-09 | Grant / award | 7,000 | $0.00 | 25,681 |
| 2021-06-04 | Open-market sale | 2,117 | $61.04 | 18,681 |
| 2020-08-03 | Option exercise (derivative) | 2,500 | $0.00 | 7,500 |
| 2020-08-03 | Open-market sale | 2,500 | $52.68 | 20,796 |
| 2020-08-03 | Option exercise | 2,500 | $44.10 | 22,750 |
| 2020-06-29 | Option exercise (derivative) | 15,000 | $0.00 | 15,000 |
| 2020-06-29 | Option exercise (derivative) | 7,500 | $0.00 | 22,500 |
| 2020-06-29 | Option exercise (derivative) | 30,000 | $0.00 | 10,000 |
| 2020-06-29 | Option exercise (derivative) | 3,750 | $0.00 | 6,250 |
| 2020-06-29 | Open-market sale | 6,859 | $51.77 | 22,028 |
| 2020-06-29 | Open-market sale | 51,464 | $50.01 | 28,887 |
| 2020-06-29 | Option exercise | 30,000 | $44.10 | 80,351 |
| 2020-06-29 | Open-market sale | 1,778 | $52.03 | 20,250 |
| 2020-06-29 | Option exercise | 15,000 | $38.35 | 42,851 |
| 2020-06-29 | Option exercise | 3,750 | $37.81 | 27,851 |
| 2020-06-29 | Option exercise | 7,500 | $43.54 | 50,351 |
| 2020-06-09 | Grant / award (derivative) | 35,000 | $0.00 | 35,000 |
| 2020-06-09 | Grant / award | 14,000 | $0.00 | 24,101 |
| 2020-06-04 | Open-market sale | 863 | $46.33 | 10,101 |
| 2019-06-05 | Grant / award (derivative) | 30,000 | $0.00 | 30,000 |
| 2019-06-05 | Grant / award | 5,000 | $0.00 | 10,367 |
| 2019-06-04 | Open-market sale | 430 | $42.91 | 5,367 |
| 2018-06-13 | Grant / award (derivative) | 30,000 | $0.00 | 30,000 |
| 2018-06-13 | Grant / award | 5,000 | $0.00 | 5,238 |
| 2018-06-13 | — | — | — | 238 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.